Bone Cancer Treatment Market – Global Industry Analysis 2024

Bone Cancer Treatment Market Overview

Cancer is one of the most prevalent fatal chronic disorders with a high mortality rate due to its extremely invasive nature and prolonged duration of disease. Bone cancer is a type of cancer in which the bone tissues grows in an uncontrollable manner. This growth may be benign or malignant. In most cases bone cancer results from other cancers such as lung cancer, kidney cancer, prostate cancer, and breast cancer, which is also called secondary or metastatic bone cancer. The major and primary symptom of bone cancer is severe bone pain, which usually intensifies with time. In addition to pain, symptoms such as weight loss, fever, fatigue, muscle pain, bone crack, osteoporosis and osteopenia are also identified. Diagnosis of bone cancer includes understanding patient’s history and reasons causing pain. Besides, bone cancer can be diagnosed using imaging techniques such as computerized tomography (CT), bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and biopsy tests.

Get Free PDF Research Brochure for more Professional and Technical Insights:https://www.coherentmarketinsights.com/insight/request-sample/93

Bone cancer treatment market can be classified on basis of type and treatment available for bone cancer

The bone cancer treatment market is analyzed on the basis of type of bone cancer into primary bone cancer and secondary bone cancer. Primary bone cancer originates from fast and uncontrollable growth of the bone and other related tissues. Types of primary bone cancer include osteosarcoma, chondrosarcoma, Ewing’s sarcoma, spindle cell sarcoma, and chordoma. Secondary bone cancer, also called metastatic bone cancer, arises due to spreading of cancer cells from different parts of body. It is also referred as metastatic bone cancer.

On the basis of therapies or treatments available, the global bone cancer treatment market is classified as radiation therapy, chemotherapy, cryosurgery, and surgical treatments. The major surgical practices used to treat bone cancer are limb amputation surgery and limb salvage surgery or limb sparing surgery. In radiation therapy, high energy X-rays or gamma-rays are used to destroy tumors. Chemotherapy is a pharmacological treatment that involves the use of anti-cancer drugs. Major drugs include strontium-89 chloride, bisphosphonates, methotrexate, and doxorubicin, among others. Cryosurgery is sometimes used in lieu of conventional surgery to kill tumors.

Increasing disease incidence creating favorable growth environment for Bone cancer treatment market

Developed markets such as the U.S., U.K., Japan, Canada, Australia, Germany, and Spain have a robust healthcare infrastructure that provides patients with easy access to advanced healthcare facilities, which aids in early diagnosis of bone cancer. According to the American Cancer Society (ACS), approximately 3,300 new cases of bone cancer are expected to be diagnosed in 2016, resulting in around 1,490 deaths in the same year. Moreover, the ACS sates that in adults over 40% of primary bone cancers are chondrosarcomas. This is followed by osteosarcomas (28%), chordomas (10%), Ewing tumors (8%), and malignant fibrous histiocytoma/fibrosarcomas (4%). According to 2016 Cancer.Net estimates, 3,300 people of all ages in the U.S. would be diagnosed with primary bone cancer. New cases of bone cancer being diagnosed would propel growth of the bone cancer treatment market in the U.S. On the other hand, rising incidence rate in Asia Pacific is expected to be a major growth factor for the global bone cancer treatment market, supported by growing awareness among the populace.

Browse Research Report At : https://www.coherentmarketinsights.com/ongoing-insight/bone-cancer-treatment-market-93

Global players involved in the bone cancer treatment market

Major players involved in bone cancer treatment market include Amgen Inc., Actavis plc, Novartis International AG, Debiopharm Group, Pfizer, Inc., and Eli Lilly and Company.

Dr. Andre Roodt, a researcher at the University of Free State has developed pain relieving drug for bone cancer patients in December 2016. The drug is a liquid radioactive isotope that can detect cancer in the body. Innovation in treatment options would lead to better therapeutic outcomes.

ABOUT US
COMPANY OVERVIEW
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. Our global team of over 100 research analysts and freelance consultants provide market intelligence from the very molecular country level and also provide a global perspective of the market. Our team is of the most vital cog in our robust machinery that gives us the ability to deliver independent insight relying on our cognitive defusion training module.This allows for an objective and unbiased assessment of the market. We pride ourselves in my constantly striving to update our extremely in-depth understanding of the market by closely monitoring and analyzing markets, trends, and emerging best practices, across allfathomable industries under the sun. This enables us to equip our valued clientele with key decisive inputs to capitalize on lucrative growth opportunities in the market and to follow firmly position themselves on a high growth path in the future.

CONTACT US
CORPORATE OFFICE :
Coherent Market Insights
303, Astral Court,Above Reliance Fresh,
Near Gaikwad Petrol Pump,
Aundh, Pune – 411045, India
Mail Id : sales@coherentmarketinsights.com
Visit Blog : http://globalresearchtrends.blogspot.in/

This release was published on openPR.